![Hubert Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/07/2026
Hubert C.
Chen is Chief Medical Officer at Viking Therapeutics, Inc. since 2026.
Former positions include President & Chief Scientific Officer at Forte Biosciences, Inc. from 2022 to 2024; Chief Medical Officer at Metacrine, Inc. from 2018 to 2021; Chief Medical & Scientific Officer at Pelican, Inc. from 2014 to 2018; Vice President-Clinical Development at Rein Therapeutics, Inc. from 2013 to 2014; Vice President-Translational Medicine at Regulus Therapeutics, Inc. from 2009 to 2012; Assistant Clinical Professor at The University of California, San Francisco from 2002 to 2012; Associate Director-Medical Sciences at Amgen, Inc. from 2004 to 2006; Senior Director-Clinical Research at Amylin Pharmaceuticals, Inc.; and Staff Research Investigator at The J.
David Gladstone Institutes.
Education includes a doctorate from The Trustees of Columbia University in The City of New York in 1995 and an undergraduate degree from Stanford University in 1991.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| VIKING THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 11/06/2026 |
| Società | Posizione | Fine |
|---|---|---|
| FORTE BIOSCIENCES | Presidente | 15/03/2024 |
| METACRINE, INC. | Direttore Tecnico/Scientifico/R&S | 31/12/2021 |
| PFENEX INC. | Direttore Tecnico/Scientifico/R&S | 02/09/2018 |
| REIN THERAPEUTICS INC. | Corporate Officer/Principal | 01/10/2014 |
| REGULUS THERAPEUTICS INC. | Corporate Officer/Principal | 01/01/2012 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The J. David Gladstone Institutes
 The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology | Commercial Services |
Regulus Therapeutics, Inc.
 Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
Pelican Inc
 Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Viking Therapeutics, Inc.
 Viking Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic and endocrine disorders | Health Technology |
Metacrine, Inc.
 Metacrine, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
Forte Biosciences, Inc.
 Forte Biosciences, Inc. BiotechnologyHealth Technology Provides dermatological therapies and related services | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
